These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23944710)

  • 1. Impact of dose-finding studies on administration of oxytocin during caesarean section in the UK.
    West R; West S; Simons R; McGlennan A
    Anaesthesia; 2013 Oct; 68(10):1021-5. PubMed ID: 23944710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of oxytocin to prevent haemorrhage at caesarean section--a survey of practice in the United Kingdom.
    Wedisinghe L; Macleod M; Murphy DJ
    Eur J Obstet Gynecol Reprod Biol; 2008 Mar; 137(1):27-30. PubMed ID: 17544563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study protocol. ECSSIT - Elective Caesarean Section Syntocinon Infusion Trial. A multi-centre randomised controlled trial of oxytocin (Syntocinon) 5 IU bolus and placebo infusion versus oxytocin 5 IU bolus and 40 IU infusion for the control of blood loss at elective caesarean section.
    Murphy DJ; Carey M; Montgomery AA; Sheehan SR;
    BMC Pregnancy Childbirth; 2009 Aug; 9():36. PubMed ID: 19703279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Australian and New Zealand survey of practice of the use of oxytocin at elective caesarean section.
    Mockler JC; Murphy DJ; Wallace EM
    Aust N Z J Obstet Gynaecol; 2010 Feb; 50(1):30-5. PubMed ID: 20218994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxytocin for labour and caesarean delivery: implications for the anaesthesiologist.
    Dyer RA; Butwick AJ; Carvalho B
    Curr Opin Anaesthesiol; 2011 Jun; 24(3):255-61. PubMed ID: 21415725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey on the use of oxytocin for cesarean section.
    Marcus HE; Fabian A; Lier H; Dagtekin O; Böttiger BW; Teschendorf P; Petzke F; Valter M; Spöhr F
    Minerva Anestesiol; 2010 Nov; 76(11):890-5. PubMed ID: 20592672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of guidelines on oxytocin use at caesarean section: a survey of practice in Great Britain and Ireland.
    Sheehan SR; Wedisinghe L; Macleod M; Murphy DJ
    Eur J Obstet Gynecol Reprod Biol; 2010 Feb; 148(2):121-4. PubMed ID: 19896761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review of oxytocin dosing at caesarean section.
    Stephens LC; Bruessel T
    Anaesth Intensive Care; 2012 Mar; 40(2):247-52. PubMed ID: 22417018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ED
    Qian XW; Drzymalski DM; Lv CC; Guo FH; Wang LY; Chen XZ
    BMC Pregnancy Childbirth; 2019 Dec; 20(1):6. PubMed ID: 31892352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous oxytocin bolus of 2 units is superior to 5 units during elective Caesarean section.
    Sartain JB; Barry JJ; Howat PW; McCormack DI; Bryant M
    Br J Anaesth; 2008 Dec; 101(6):822-6. PubMed ID: 18845650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimum effective bolus dose of oxytocin during elective Caesarean delivery.
    Butwick AJ; Coleman L; Cohen SE; Riley ET; Carvalho B
    Br J Anaesth; 2010 Mar; 104(3):338-43. PubMed ID: 20150347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two oxytocin administration protocols in elective cesarean section: 5 iu versus 10 iu.
    Derbel M; Mekki D; Riahi A; Dimassi K; Mebazaa MS; Gara MF
    Tunis Med; 2016 Apr; 94(4):253-258. PubMed ID: 27704507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison the effects of oxytocin and methylergonovine in elective caesarean section under spinal anesthesia.
    Anvaripour A; Shahryari H; Ahmadi S; Ghasemi S; Mirzaei K
    Arch Gynecol Obstet; 2013 May; 287(5):979-83. PubMed ID: 23250341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxytocin use during Caesarean sections in Denmark - are we getting the dose right?
    Kjaer BN; Krøigaard M; Garvey LH
    Acta Anaesthesiol Scand; 2016 Jan; 60(1):18-25. PubMed ID: 26338081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ST depression at caesarean section and the relation to oxytocin dose. A randomised controlled trial.
    Jonsson M; Hanson U; Lidell C; Nordén-Lindeberg S
    BJOG; 2010 Jan; 117(1):76-83. PubMed ID: 19781043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal haemodynamics at elective caesarean section: a randomised comparison of oxytocin 5-unit bolus and placebo infusion with oxytocin 5-unit bolus and 30-unit infusion.
    McLeod G; Munishankar B; MacGregor H; Murphy DJ
    Int J Obstet Anesth; 2010 Apr; 19(2):155-60. PubMed ID: 20194013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective study to investigate the possible relationship between excess blood loss at caesarean section and reduced intra-operative oxytocin dose.
    Pearson GA; Pepper W; Russell R; MacKenzie IZ
    Eur J Obstet Gynecol Reprod Biol; 2016 Jan; 196():31-7. PubMed ID: 26656199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A survey of anaesthetists on uterotonic usage practices for elective caesarean section in Australia and New Zealand.
    Terblanche NC; Otahal P; Sharman JE
    Anaesth Intensive Care; 2021 Nov; 49(6):440-447. PubMed ID: 34657486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum oxytocin concentrations in elective caesarean delivery: a randomized comparison of three infusion regimens.
    Yamaguchi ET; Cardoso MM; Torres ML; Nascimento RC; Ribeiro MC; Frerichs E; Payen D
    Int J Obstet Anesth; 2011 Jul; 20(3):224-8. PubMed ID: 21641198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paucity of evidence for the effectiveness of prophylactic low-dose oxytocin protocols (<5 IU) compared with 5 IU in women undergoing elective caesarean section: A systematic review of randomised controlled trials.
    Terblanche NCS; Picone DS; Otahal P; Sharman JE
    Eur J Anaesthesiol; 2018 Dec; 35(12):987-989. PubMed ID: 30376493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.